Bone Morphogenetic Proteins (BMPs), which are morphogens in the TGFβ superfamily, have shown promise in suppressing glioblastoma initiating cells, likely by reprogramming them into terminally differentiated phenotypes [1,9]. The gene discussed is TGFB1; the disease is glioblastoma.